---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-057514"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2024-05-06T23:59:59+00:00"
generated_at: "2026-06-02T21:46:22.801136+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents amends bylaws: adds forum selection clause, updates advance notice provisions

## Summary
- Amended bylaws effective May 2, 2024; removes stockholder list inspection requirement per DGCL update.
- Updated advance notice disclosure requirements for stockholder proposals and director nominations.
- Deleted requirement for stockholder action to be at a duly called meeting, consistent with DGCL.
- Added forum selection clause: internal affairs litigated in Delaware; securities claims in federal court.

## SEC filing metadata
- accession: 0001104659-24-057514
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2024-05-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465924057514/0001104659-24-057514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465924057514/tm2413387d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-057514
- JSON: https://secwatch.observer/filing/0001104659-24-057514.json
- Plain text: https://secwatch.observer/filing/0001104659-24-057514.txt

## Key facts
- Governance Changes
  Cytosorbents Corp: Amended and restated bylaws to delete stockholder list examination requirement, update advance notice disclosure requirements, delete requirement for stockholder action at meetings, and add forum selection clause (effective 2024-05-02).
  - Change: bylaw amendment
  - Effective: 2024-05-02
  source text: On May 2, 2024, the Board of Directors (the “Board”) of CytoSorbents Corporation (the “Company”) approved the Second Amended and Restated Bylaws of the Company (the “Bylaws”), which became effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465924057514/0001104659-24-057514-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.